Safety and tolerability following single dose of ONO-9054 in healthy volunteers

被引:0
|
作者
Rowe-Rendleman, Cheryl [1 ]
Ouchi, Takafumi [2 ]
Ross, Douglas [2 ]
Wood, Andrew [2 ]
机构
[1] Ono Pharma Omar Consulting Grp LLC, Preclin, Princeton Jct, NJ USA
[2] Ono Pharma USA, Drug Dev, Lawrenceville, NJ USA
关键词
466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials; 675 receptors: pharmacology/physiology; 503 drug toxicity/drug effects;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
440
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Single dose pharmacokinetics of ONO-9054 in healthy volunteers
    Ouchi, Takafumi
    Rowe-Rendleman, Cheryl
    Ross, Douglas
    Suto, Fumitaka
    Wood, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
    Suto, Fumitaka
    Rowe-Rendleman, Cheryl L.
    Ouchi, Takafumi
    Jamil, Alam
    Wood, Andrew
    Ward, Caroline L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (13) : 7963 - 7970
  • [3] Comparative IOP lowering from single dose studies of latanoprost, timolol and ONO-9054 in Dogs and Monkeys
    Nagai, Kazufumi
    Yamane, Shinsaku
    Moriyuki, Kazumi
    Karakawa, Tomohiro
    Nakao, Shintaro
    Shiroya, Tsutomu
    Shichino, Yutaka
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [4] Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers
    Barbour, April M.
    Sarov-Blat, Lea
    Cai, Gengqian
    Fossler, Michael J.
    Sprecher, Dennis L.
    Graggaber, Johann
    McGeoch, Adam T.
    Maison, Jo
    Cheriyan, Joseph
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (01) : 99 - 106
  • [5] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
    Maria Rosario
    Timothy Wyant
    Timothy Leach
    Serap Sankoh
    Catherine Scholz
    Asit Parikh
    Irving Fox
    Brian G. Feagan
    Clinical Drug Investigation, 2016, 36 : 913 - 923
  • [6] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
    Rosario, Maria
    Wyant, Timothy
    Leach, Timothy
    Sankoh, Serap
    Scholz, Catherine
    Parikh, Asit
    Fox, Irving
    Feagan, Brian G.
    CLINICAL DRUG INVESTIGATION, 2016, 36 (11) : 913 - 923
  • [7] Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers
    Khera, Himanshi
    Pandey, Avaneesh Kumar
    Shafiq, Nusrat
    Khuller, G. K.
    Bhandari, Ritika Kondel
    Panditrao, Aditi
    Gamad, Nanda
    Rohilla, Rachna
    Bhattacharjee, Samiksha
    Murali, Naveen
    Cvn, Harish
    Belavagi, Devraj
    Mothsara, Chakrant
    Singh, Manjula
    Sharma, Navneet
    Behera, Digamber
    Malhotra, Samir
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 955 - 961
  • [8] Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers
    Vanover, Kimberly E.
    Robbins-Weilert, Doris
    Wilbraham, Darren G.
    Mant, Timothy G. K.
    van Kammen, Daniel P.
    Davis, Robert E.
    Weiner, David M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (06): : 704 - 714
  • [9] Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers
    Rodríguez, CA
    Azie, NE
    Adams, G
    Donaldson, K
    Francom, SF
    Staton, BA
    Bombardt, PA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (03): : 276 - 283
  • [10] Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers
    Kunka, RL
    Hussey, EK
    Shaw, S
    Warner, P
    Aubert, B
    Richard, I
    Fowler, PA
    Pakes, GE
    CEPHALALGIA, 1997, 17 (04) : 532 - 540